Unresectable Colorectal Adenocarcinoma
2 clinical trials · Condition
◉ Watch Unresectable Colorectal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer (NCT07147231) | National Cancer Institute (NCI) | 2026-08-10 |
| Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer (NCT06696768) | National Cancer Institute (NCI) | 2025-06-23 |
Track Unresectable Colorectal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.